Browse > Article
http://dx.doi.org/10.5230/jgc.2022.22.e32

Safe Discharge Criteria After Curative Gastrectomy for Gastric Cancer  

Guner, Ali (Department of Surgery, Yonsei University College of Medicine)
Kim, Ki Yoon (Department of Surgery, Yonsei University College of Medicine)
Park, Sung Hyun (Department of Surgery, Yonsei University College of Medicine)
Cho, Minah (Department of Surgery, Yonsei University College of Medicine)
Kim, Yoo Min (Department of Surgery, Yonsei University College of Medicine)
Hyung, Woo Jin (Department of Surgery, Yonsei University College of Medicine)
Kim, Hyoung-Il (Department of Surgery, Yonsei University College of Medicine)
Publication Information
Journal of Gastric Cancer / v.22, no.4, 2022 , pp. 395-407 More about this Journal
Abstract
Purpose: This study aimed to investigate the relationship between clinical and laboratory parameters and complication status to predict which patients can be safely discharged from the hospital on the third postoperative day (POD). Materials and Methods: Data from a prospectively maintained database of 2,110 consecutive patients with gastric adenocarcinoma who underwent curative surgery were reviewed. The third POD vital signs, laboratory data, and details of the course after surgery were collected. Patients with grade II or higher complications after the third POD were considered unsuitable for early discharge. The performance metrics were calculated for all algorithm parameters. The proposed algorithm was tested using a validation dataset of consecutive patients from the same center. Results: Of 1,438 patients in the study cohort, 142 (9.9%) were considered unsuitable for early discharge. C-reactive protein level, body temperature, pulse rate, and neutrophil count had good performance metrics and were determined to be independent prognostic factors. An algorithm consisting of these 4 parameters had a negative predictive value (NPV) of 95.9% (95% confidence interval [CI], 94.2-97.3), sensitivity of 80.3% (95% CI, 72.8-86.5), and specificity of 51.1% (95% CI, 48.3-53.8). Only 28 (1.9%) patients in the study cohort were classified as false negatives. In the validation dataset, the NPV was 93.7%, sensitivity was 66%, and 3.3% (17/512) of patients were classified as false negatives. Conclusions: Simple clinical and laboratory parameters obtained on the third POD can be used when making decisions regarding the safe early discharge of patients who underwent gastrectomy.
Keywords
Gastric cancer; Gastrectomy; Postoperative complications; Discharge; Readmission;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer 2019;19:1-48.   DOI
2 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 2021;24:1-21.   DOI
3 Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-196.   DOI
4 Korevaar DA, Gopalakrishna G, Cohen JF, Bossuyt PM. Targeted test evaluation: a framework for designing diagnostic accuracy studies with clear study hypotheses. Diagn Progn Res 2019;3:22.   DOI
5 Korner H, Nielsen HJ, Soreide JA, Nedrebo BS, Soreide K, Knapp JC. Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections. J Gastrointest Surg 2009;13:1599-1606.   DOI
6 Welsch T, Muller SA, Ulrich A, Kischlat A, Hinz U, Kienle P, et al. C-reactive protein as early predictor for infectious postoperative complications in rectal surgery. Int J Colorectal Dis 2007;22:1499-1507.   DOI
7 Guner A, Kim SY, Yu JE, Min IK, Roh YH, Roh C, et al. Parameters for predicting surgical outcomes for gastric cancer patients: simple is better than complex. Ann Surg Oncol 2018;25:3239-3247.   DOI
8 Park JH, Son YG, Kim TH, Huh YJ, Yang JY, Suh YJ, et al. Identification of candidates for early discharge after gastrectomy. Ann Surg Oncol 2017;24:159-166.   DOI
9 Tian Y, Cao S, Liu X, Li L, He Q, Jiang L, et al. Randomized controlled trial comparing the short-term outcomes of enhanced recovery after surgery and conventional care in laparoscopic distal gastrectomy (GISSG1901). Ann Surg 2022;275:e15-e21.   DOI
10 Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th ed. Cham: Springer International Publishing; 2017.
11 Guner A, Kim HI. Biomarkers for evaluating the inflammation status in patients with cancer. J Gastric Cancer 2019;19:254-277.   DOI
12 Information Committee of the Korean Gastric Cancer Association. Korean Gastric Cancer Association-led nationwide survey on surgically treated gastric cancers in 2019. J Gastric Cancer 2021;21:221-235.   DOI
13 Viyuela Garcia C, Medina Fernandez FJ, Arjona-Sanchez A, Casado-Adam A, Sanchez Hidalgo JM, Rufian Pena S, et al. Systemic inflammatory markers for the detection of infectious complications and safe discharge after cytoreductive surgery and HIPEC. Surg Oncol 2020;34:163-167.   DOI
14 Shannon AB, Straker RJ 3rd, Fraker DL, Roses RE, Miura JT, Karakousis GC. Ninety-day mortality after total gastrectomy for gastric cancer. Surgery 2021;170:603-609.   DOI
15 Park SH, Kang MJ, Yun EH, Jung KW. Epidemiology of gastric cancer in Korea: trends in incidence and survival based on Korea Central Cancer Registry data (1999-2019). J Gastric Cancer 2022;22:160-168.   DOI
16 Weindelmayer J, Mengardo V, Gasparini A, Sacco M, Torroni L, Carlini M, et al. Enhanced recovery after surgery can improve patient outcomes and reduce hospital cost of gastrectomy for cancer in the west: a propensity-score-based analysis. Ann Surg Oncol 2021;28:7087-7094.   DOI
17 Roh CK, Son SY, Lee SY, Hur H, Han SU. Clinical pathway for enhanced recovery after surgery for gastric cancer: a prospective single-center phase II clinical trial for safety and efficacy. J Surg Oncol 2020;121:662-669.   DOI
18 Roh CK, Choi S, Seo WJ, Cho M, Choi YY, Son T, et al. Comparison of surgical outcomes between integrated robotic and conventional laparoscopic surgery for distal gastrectomy: a propensity score matching analysis. Sci Rep 2020;10:485.   DOI
19 Tavernier C, Flaris AN, Passot G, Glehen O, Kepenekian V, Cotte E. Assessing criteria for a safe early discharge after laparoscopic colorectal surgery. JAMA Surg 2022;157:52-58.   DOI
20 Zhao J, Hu J, Jiang Z, Wang G, Liu J, Wang H, et al. Outcome of discharge within 72 hours of robotic gastrectomy using enhanced recovery after surgery programs. J Laparoendosc Adv Surg Tech A 2018;28:1279-1286.   DOI
21 Yeung DE, Peterknecht E, Hajibandeh S, Hajibandeh S, Torrance AW. C-reactive protein can predict anastomotic leak in colorectal surgery: a systematic review and meta-analysis. Int J Colorectal Dis 2021;36:1147-1162.   DOI
22 Lee YM, Cho JY, Sung TY, Kim TY, Chung KW, Hong SJ, et al. Clinicopathological risk factors and biochemical predictors of safe discharge after total thyroidectomy and central compartment node dissection for thyroid cancer: a prospective study. Int J Endocrinol 2015;2015:214525.
23 van Winsen M, McSorley ST, McLeod R, MacDonald A, Forshaw MJ, Shaw M, et al. Postoperative C-reactive protein concentrations to predict infective complications following gastrectomy for cancer. J Surg Oncol 2021;124:1060-1069.   DOI
24 Yang W, Chen X, Zhang P, Li C, Liu W, Wang Z, et al. Procalcitonin as an early predictor of intraabdominal infections following gastric cancer resection. J Surg Res 2021;258:352-361.   DOI
25 Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC. Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg 2011;35:1017-1025.   DOI
26 Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016;315:762-774.   DOI
27 Yu D, Wu X, Li X, Liu X, Jiang K, Zhao Q, et al. Development and external validation of safe discharge criteria after radical gastrectomy. Cancer Manag Res 2021;13:5251-5261.   DOI
28 Guner A, Cho M, Kim YM, Cheong JH, Hyung WJ, Kim HI. Prognostic value of postoperative neutrophil and albumin: reassessment one month after gastric cancer surgery. Front Oncol 2021;11:633924.   DOI